logo
logo

Voluntis Obtains €3 Million of Additional Non-Dilutive Loans and Optimizes Its Existing Financing

Dec 18, 2020over 4 years ago

Amount Raised

€3 Million

Round Type

seed

Cambridge

Description

Regulatory News:

Company Information

Company

Voluntis

Location

Cambridge, Maryland, United States

About

Voluntis creates digital therapeutics that empower people with chronic conditions to self-manage their treatment every day, thus improving real-world outcomes. Voluntis’ solutions, combining mobile and web apps, use clinical algorithms to deliver personalized recommendations to patients and their care teams. For example, these recommendations are used to adjust treatment dosage, manage side effects or monitor symptoms. Leveraging its Theraxium® technology platform, Voluntis has designed and operates multiple digital therapeutics, especially in oncology and diabetes. Voluntis has long-standing partnerships with leading life science companies. Based in Cambridge, MA, and Paris, France, Voluntis is a founding member of the Digital Therapeutics Alliance. For more information, please visit: www.voluntis.com

Related People